Development and Implementation of a Comprehensive, Multidisciplinary Emergency Department Extracorporeal Membrane Oxygenation Program - 27/09/17

, Craig H. Selzman, MD, FACS a, Michael P. Mallin, MD b, Brigham R. Smith, MD d, Scott T. Youngquist, MD, MSc b, Antigoni Koliopoulou, MD a, Frederick Welt, MD d, Kathleen Diane Stoddard, RN, BSN, CCRN e, Ram Nirula, MD, MPH, FACS c, Richard Barton, MD c, James Franklin Fair, MD b, James C. Fang, MD, FACC, FAHA f, Stephen McKellar, MD, MSc aAbstract |
Despite advances in the medical and surgical management of cardiovascular disease, greater than 350,000 patients experience out-of-hospital cardiac arrest in the United States annually, with only a 12% neurologically favorable survival rate. Of these patients, 23% have an initial shockable rhythm of ventricular fibrillation/pulseless ventricular tachycardia (VF/VT), a marker of high probability of acute coronary ischemia (80%) as the precipitating factor. However, few patients (22%) will experience return of spontaneous circulation and sufficient hemodynamic stability to undergo cardiac catheterization and revascularization. Previous case series and observational studies have demonstrated the successful application of intra-arrest extracorporeal life support, including to out-of-hospital cardiac arrest victims, with a neurologically favorable survival rate of up to 53%. For patients with refractory cardiac arrest, strategies are needed to bridge them from out-of-hospital cardiac arrest to the catheterization laboratory and revascularization. To address this gap, we expanded our ICU and perioperative extracorporeal membrane oxygenation (ECMO) program to the emergency department (ED) to reach this cohort of patients to improve survival. In this report, we illustrate our process and initial experience of developing a multidisciplinary team for rapid deployment of ED ECMO as a template for institutions interested in building their own ED ECMO programs.
Le texte complet de cet article est disponible en PDF.Plan
| Supervising editor: Keith A. Marill, MD |
|
| Author contributions: All authors made substantial contributions to all of the following: concept and design of the study, acquisition of data, and analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and final approval of the version to be submitted. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist. Dr. Welt reports receiving consulting fees from Medtronic Advisory Board outside the scope of the submitted work. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 70 - N° 1
P. 32-40 - juillet 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
